Related Experiment Video
Updated: Jul 19, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Iris metastatic thyroid follicular carcinoma: a case report]
I Chtourou1, A Khabir, Z Benzina
1Laboratoire d'Anatomie et de Cytologie Pathologiques, CHU Habib Bourguiba, Sfax, Tunisie.
Journal Francais D'Ophtalmologie
|November 1, 2006
Summary
Metastatic carcinoma of the iris is a rare condition, often originating from breast or lung cancer. This case highlights an unusual instance of follicular thyroid carcinoma metastasizing to the iris.
Area of Science:
- Ophthalmology
- Oncology
- Pathology
Background:
- Metastatic carcinoma to the iris is uncommon, representing a small percentage of uveal metastases and iris lesions.
- Breast and lung cancers are the most frequent primary sites for iris metastases.
Observation:
- A 66-year-old man with a history of follicular thyroid carcinoma presented with a pink, vascularized iris mass.
- No local recurrence or distant metastases were noted at the time of iris metastasis diagnosis.
Findings:
- Histopathological examination confirmed the iris mass as follicular thyroid metastasis carcinoma.
- The patient declined adjuvant therapy and was monitored for 23 months post-diagnosis.
Implications:
- This case underscores the rare occurrence of follicular thyroid carcinoma metastasis to the iris.
- Further review discusses the clinicopathological features and prognosis of this exceptional metastatic site.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...